ボツリヌス症(Botulism):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Botulism Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2434CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月28日
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるボツリヌス症(Botulism) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - ボツリヌス症(Botulism)
  - 当レポートの概要
・ボツリヌス症(Botulism):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Botulism Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Botulism Global Clinical Trials Review, H2, 2014″ provides data on the Botulism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Botulism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Botulism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Botulism 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Botulism to Infectious Disease Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Botulism to Infectious Disease Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Botulism 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Botulism Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Emergent BioSolutions Inc. 26
Clinical Trial Overview of Emergent BioSolutions Inc. 26
DynPort Vaccine Company LLC 27
Clinical Trial Overview of DynPort Vaccine Company LLC 27
Merz Pharma GmbH & Co. KgaA 28
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 28
Medy-Tox Inc. 29
Clinical Trial Overview of Medy-Tox Inc. 29
Clinical Trial Overview of Top Institutes / Government 30
California Department of Public Health 30
Clinical Trial Overview of California Department of Public Health 30
Centre Hospitalier Universitaire, Amiens 31
Clinical Trial Overview of Centre Hospitalier Universitaire, Amiens 31
Chinese PLA General Hospital 32
Clinical Trial Overview of Chinese PLA General Hospital 32
FDA Office of Orphan Products Development 33
Clinical Trial Overview of FDA Office of Orphan Products Development 33
Rajavithi Hospital foundation 34
Clinical Trial Overview of Rajavithi Hospital foundation 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
Five Key Clinical Profiles 36
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 56

List of Tables
Botulism Therapeutics, Global, Clinical Trials by Region, 2014* 6
Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Botulism Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Botulism Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 12
Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Botulism to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 15
Botulism Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Botulism Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Botulism Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Botulism Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014* 26
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by DynPort Vaccine Company LLC, 2014* 27
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 28
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 29
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by California Department of Public Health, 2014* 30
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire, Amiens, 2014* 31
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese PLA General Hospital, 2014* 32
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014* 33
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Rajavithi Hospital foundation, 2014* 34
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35

List of Figures
Botulism Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Botulism Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 12
Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Botulism to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 15
Botulism Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Botulism Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 55

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ボツリヌス症(Botulism):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆